Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liver scan & chat in hospital may cut Booze-Related ER visits

NCT ID NCT07637539

Disease control Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving hospitalized heavy drinkers a liver stiffness scan and personalized alcohol counseling can reduce future emergency hospital visits. 500 adults at risk of alcohol-related liver disease will be randomly assigned to get this extra support or usual care. Researchers will track hospital records for 2 years to see if the proactive approach leads to fewer emergencies and better health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

May 2038

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Emergency hospitalized for any reason in any participating centre 2. Adults 18 years or older 3. Harmful alcohol use, defined as AUDIT-C ≥6 (for men) or AUDIT-C ≥5 (for women) 4. Moderate to high risk of liver fibrosis, defined as FIB-4 \>1.3 5. Signed informed consent Exclusion Criteria: 1. Decompensated liver disease that impedes intervention delivery, defined as one or more of the following: 1. Moderate or severe ascites 2. Overt hepatic encephalopathy (West Haven grade ≥2) 3. Acute-on-chronic liver failure requiring admission to intensive care unit 2. Acute hepatitis of any aetiology, defined as ALT or AST \>5 x upper limit of normal (ULN) 3. Unable to participate for any reason in the opinion of the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse alcoholic liver disease cirrhosis of liver

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol use disorder Alcoholic liver disease (ALD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Akershus University Hospital

    Lørenskog, Norway

  • Diakonhjemmet Hospital

    Oslo, Norway

  • Haraldsplass Deaconess Hospital

    Bergen, Norway

  • Lovisenberg Diaconal Hospital

    Oslo, Norway

  • Oslo University Hospital

    Oslo, Norway

  • Sykehuset Innlandet Lillehammer

    Lillehammer, Norway

  • Sykehuset Nord-Trøndelag Levanger

    Levanger, Norway

  • Vestre Viken Bærum Hospital

    Drammen, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.